Current management of locally recurrent rectal cancer

Colorectal Disease

Volumn 13, Issue 7, 2011, Pages 732-742

  Nielsen, M B ^a   Laurberg, S ^a   Holm, T ^a,b  

^a AARHUS UNIVERSITY HOSPITAL   (Denmark)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Locally recurrent rectal cancer; Outcome; Review; Surgery; TME

Indexed keywords

CANCER ADJUVANT THERAPY; CANCER GRADING; CANCER RADIOTHERAPY; CANCER RISK; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COCHRANE LIBRARY; COMPUTER ASSISTED TOMOGRAPHY; DISEASE FREE SURVIVAL; EMBASE; FOLLOW UP; HUMAN; INTRAOPERATIVE RADIOTHERAPY; LYMPH NODE METASTASIS; MEDLINE; NUCLEAR MAGNETIC RESONANCE IMAGING; OVERALL SURVIVAL; PALLIATIVE THERAPY; POSITRON EMISSION TOMOGRAPHY; POSTOPERATIVE COMPLICATION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; QUALITY OF LIFE; RADIATION DOSE; RECTUM ABDOMINOPERINEAL RESECTION; RECTUM CANCER; RECTUM HEMORRHAGE; RECTUM SURGERY; RECURRENT CANCER; REVIEW; SYSTEMATIC REVIEW;

HUMANS; NEOPLASM RECURRENCE, LOCAL; POSTOPERATIVE COMPLICATIONS; QUALITY OF LIFE; RECTAL NEOPLASMS; RISK FACTORS;

EID: 79958694555     PISSN: 14628910     EISSN: 14631318     Source Type: Journal    
DOI: 10.1111/j.1463-1318.2009.02167.x     Document Type: Review

References (70)

1. Heald RJ, Husband EM, Ryall RD. The mesorectum in rectal cancer surgery - the clue to pelvic recurrence? Br J Surg 1982; 69: 613-6.
2. Heald RJ, Ryall RD. Recurrence and survival after total mesorectal excision for rectal cancer. Lancet 1986; 1: 1479-82.
3. Heald RJ. The 'Holy Plane' of rectal surgery. J R Soc Med 1988; 81: 503-8.
4. Heald RJ, Karanjia ND. Results of radical surgery for rectal cancer. World J Surg 1992; 16: 848-57.
5. Manfredi S, Benhamiche AM, Meny B, Cheynel N, Rat P, Faivre J. Population-based study of factors influencing occurrence and prognosis of local recurrence after surgery for rectal cancer. Br J Surg 2001; 88: 1221-7.
6. Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol 2007; 14: 447-54.
7. Bakx R, Visser O, Josso J, Meijer S, Slors JF, van Lanschot JJ. Management of recurrent rectal cancer: a population based study in greater Amsterdam. World J Gastroenterol 2008; 14: 6018-23.
8. de Chaisemartin C, Penna C, Goere D et al. Presentation and prognosis of local recurrence after total mesorectal excision. Colorectal Dis 2009; 11: 60-6.
9. Kakuda JT, Lamont JP, Chu DZ, Paz IB. The role of pelvic exenteration in the management of recurrent rectal cancer. Am J Surg 2003; 186: 660-4.
10. Wells BJ, Stotland P, Ko MA et al. Results of an aggressive approach to resection of locally recurrent rectal cancer. Ann Surg Oncol 2007; 14: 390-5.
11. Dresen RC, Gosens MJ, Martijn H et al. Radical resection after IORT-containing multimodality treatment is the most important determinant for outcome in patients treated for locally recurrent rectal cancer. Ann Surg Oncol 2008; 15: 1937-47.
12. Boyle KM, Sagar PM, Chalmers AG, Sebag-Montefiore D, Cairns A, Eardley I. Surgery for locally recurrent rectal cancer. Dis Colon Rectum 2005; 48: 929-37.
13. Böhm B, Helfritzsch H, Thiele M, Altendorf-Hofmann A, Scheele J. Therapy results of locoregional recurrences in rectal cancer. Zentralbl Chir 2001; 126: 596-601.
14. Camilleri-Brennan J, Steele RJ. The impact of recurrent rectal cancer on quality of life. Eur J Surg Oncol 2001; 27: 349-53.
15. van den Brink M, Stiggelbout AM, van den Hout WB et al. Clinical nature and prognosis of locally recurrent rectal cancer after total mesorectal excision with or without preoperative radiotherapy. J Clin Oncol 2004; 22: 3958-64.
16. Sagar PM, Pemberton JH. Surgical management of locally recurrent rectal cancer. Br J Surg 1996; 83: 293-304.
17. Caricato M, Borzomati D, Ausania F, Valeri S, Rosignoli A, Coppola R. Prognostic factors after surgery for locally recurrent rectal cancer: an overview. Eur J Surg Oncol 2006; 32: 126-32.
18. Gunderson LL, Sosin H. Areas of failure found at reoperation (second or symptomatic look) following "curative surgery" for adenocarcinoma of the rectum. Clinicopathologic correlation and implications for adjuvant therapy. Cancer 1974; 34: 1278-92.
19. Saito N, Koda K, Takiguchi N et al. Curative surgery for local pelvic recurrence of rectal cancer. Dig Surg 2003; 20: 192-9.
20. Wanebo HJ, Antoniuk P, Koness RJ et al. Pelvic resection of recurrent rectal cancer: technical considerations and outcomes. Dis Colon Rectum 1999; 42: 1438-48.
21. Palmer G. Locally advanced rectal cancer. MD Thesis, Stockholm, Sweden. 2009.
22. Heriot AG, Byrne CM, Lee P et al. Extended radical resection: the choice for locally recurrent rectal cancer. Dis Colon Rectum 2008; 51: 284-91.
23. Wiig JN, Larsen SG, Giercksky KE. Operative treatment of locally recurrent rectal cancer. Recent Results Cancer Res 2005; 165: 136-47.
24. Miner TJ, Jaques DP, Paty PB, Guillem JG, Wong WD. Symptom control in patients with locally recurrent rectal cancer. Ann Surg Oncol 2003; 10: 72-9.
25. Valentini V, Morganti AG, Gambacorta MA et al. Preoperative hyperfractionated chemoradiation for locally recurrent rectal cancer in patients previously irradiated to the pelvis: a multicentric phase II study. Int J Radiat Oncol Biol Phys 2006; 64: 1129-39.
26. Harbour R, Miller J. A new system for grading recommendations in evidence based guidelines. BMJ 2001; 323: 334-6.
27. Iversen LH, Harling H, Laurberg S, Wille-Jorgensen P. Influence of caseload and surgical speciality on outcome following surgery for colorectal cancer: a review of evidence. Part 2: long-term outcome. Colorectal Dis 2007; 9: 38-46.
28. Iversen LH, Harling H, Laurberg S, Wille-Jorgensen P. Influence of caseload and surgical speciality on outcome following surgery for colorectal cancer: a review of evidence. Part 1: short-term outcome. Colorectal Dis 2007; 9: 28-37.
29. MacDermid E, Hooton G, MacDonald M et al. Improving patient survival with the colorectal cancer multi-disciplinary team. Colorectal Dis 2009; 11: 291-5.
30. Wille-Jorgensen P, Bulow S. The multidisciplinary team conference in rectal cancer - a step forward. Colorectal Dis 2009; 11: 231-2.
31. den Dulk M, Marijnen CA, Putter H et al. Risk factors for adverse outcome in patients with rectal cancer treated with an abdominoperineal resection in the total mesorectal excision trial. Ann Surg 2007; 246: 83-90.
32. Martling AL, Holm T, Rutqvist LE, Moran BJ, Heald RJ, Cedemark B. Effect of a surgical training programme on outcome of rectal cancer in the County of Stockholm. Stockholm Colorectal Cancer Study Group, Basingstoke Bowel Cancer Research Project. Lancet 2000; 356: 93-6.
33. Quirke P, Steele R, Monson J et al. Effect of the plane of surgery achieved on local recurrence in patients with operable rectal cancer: a prospective study using data from the MRC CR07 and NCIC-CTG CO16 randomised clinical trial. Lancet 2009; 373: 821-8.
34. Syk E, Torkzad MR, Blomqvist L, Nilsson PJ, Glimelius B. Local recurrence in rectal cancer: anatomic localization and effect on radiation target. Int J Radiat Oncol Biol Phys 2008; 72: 658-64.
35. Nagtegaal ID, van de Velde CJ, Marijnen CA, van Krieken JH, Quirke P. Low rectal cancer: a call for a change of approach in abdominoperineal resection. J Clin Oncol 2005; 23: 9257-64.
36. Asoglu O, Karanlik H, Muslumanoglu M et al. Prognostic and predictive factors after surgical treatment for locally recurrent rectal cancer: a single institute experience. Eur J Surg Oncol 2007; 33: 1199-206.
37. Holm T, Ljung A, Haggmark T, Jurell G, Lagergren J. Extended abdominoperineal resection with gluteus maximus flap reconstruction of the pelvic floor for rectal cancer. Br J Surg 2007; 94: 232-8.
38. West NP, Finan PJ, Anderin C, Lindholm J, Holm T, Quirke P. Evidence of the oncologic superiority of cylindrical abdominoperineal excision for low rectal cancer. J Clin Oncol 2008; 26: 3517-22.
39. Huebner RH, Park KC, Shepherd JE et al. A meta-analysis of the literature for whole-body FDG PET detection of recurrent colorectal cancer. J Nucl Med 2000; 41: 1177-89.
40. Schurr P, Lentz E, Block S et al. Radical redo surgery for local rectal cancer recurrence improves overall survival: a single center experience. J Gastrointest Surg 2008; 12: 1232-8.
41. Suzuki K, Gunderson LL, Devine RM et al. Intraoperative irradiation after palliative surgery for locally recurrent rectal cancer. Cancer 1995; 75: 939-52.
42. Glimelius B. Recurrent rectal cancer. The pre-irradiated primary tumour: can more radiotherapy be given? Colorectal Dis 2003; 5: 501-3.
43. Mohiuddin M, Marks G, Marks J. Long-term results of reirradiation for patients with recurrent rectal carcinoma. Cancer 2002; 95: 1144-50.
44. Braendengen M, Tveit KM, Berglund A et al. Randomized phase III study comparing preoperative radiotherapy with chemoradiotherapy in nonresectable rectal cancer. J Clin Oncol 2008; 26: 3687-94.
45. Rödel C, Grabenbauer GG, Matzel KE et al. Extensive surgery after high-dose preoperative chemoradiotherapy for locally advanced recurrent rectal cancer. Dis Colon Rectum 2000; 43: 312-9.
46. Moore HG, Shoup M, Riedel E et al. Colorectal cancer pelvic recurrences: determinants of resectability. Dis Colon Rectum 2004; 47: 1599-606.
47. Wiggers T, Mannaerts GH, Marinelli AW, Martijn H, Rutten HJ. Surgery for locally recurrent rectal cancer. Colorectal Dis 2003; 5: 504-7.
48. Sagar PM. Extended surgery for local recurrence and advanced rectal cancer. Colorectal Dis 2006; 8(Suppl 3): 43-6.
49. Henry LR, Sigurdson E, Ross E, Hoffman JP. Hydronephrosis does not preclude curative resection of pelvic recurrences after colorectal surgery. Ann Surg Oncol 2005; 12: 786-92.
50. Larsen SG, Wiig JN, Giercksky KE. Hydronephrosis as a prognostic factor in pelvic recurrence from rectal and colon carcinomas. Am J Surg 2005; 190: 55-60.
51. Abe M, Takahashi M. Intraoperative radiotherapy: the Japanese experience. Int J Radiat Oncol Biol Phys 1981; 7: 863-8.
52. Ellis RJ, Nag S, Kinsella TJ. Alternative techniques of intraoperative radiotherapy. Eur J Surg Oncol 2000; 26(Suppl A): S25-7.
53. Harrison LB, Enker WE, Anderson LL. High-dose-rate intraoperative radiation therapy for colorectal cancer. Oncology (Williston Park) 1995; 9: 737-41.
54. Harrison LB, Enker WE, Anderson LL. High-dose-rate intraoperative radiation therapy for colorectal cancer. Oncology (Williston Park) 1995; 9: 679-83.
55. Sindelar WF, Tepper J, Travis EL, Terrill R. Tolerance of retroperitoneal structures to intraoperative radiation. Ann Surg 1982; 196: 601-8.
56. Kinsella TJ, Sindelar WF, DeLuca AM et al. Tolerance of peripheral nerve to intraoperative radiotherapy (IORT): clinical and experimental studies. Int J Radiat Oncol Biol Phys 1985; 11: 1579-85.
57. Gunderson LL, Martin JK, Bèart RW et al. Intraoperative and external beam irradiation for locally advanced colorectal cancer. Ann Surg 1988; 207: 52-60.
58. Treiber M, Lehnert T, Oertel S et al. Intraoperative radiotherapy - special focus: recurrent rectal carcinoma. Front Radiat Ther Oncol 2004; 38: 52-6.
59. Vermaas M, Ferenschild FT, Nuyttens JJ et al. Preoperative radiotherapy improves outcome in recurrent rectal cancer. Dis Colon Rectum 2005; 48: 918-28.
60. Wiig JN, Tveit KM, Poulsen JP, Olsen DR, Giercksky KE. Preoperative irradiation and surgery for recurrent rectal cancer. Will intraoperative radiotherapy (IORT) be of additional benefit? A prospective study. Radiother Oncol 2002; 62: 207-13.
61. Shibata D, Hyland W, Busse P et al. Immediate reconstruction of the perineal wound with gracilis muscle flaps following abdominoperineal resection and intraoperative radiation therapy for recurrent carcinoma of the rectum. Ann Surg Oncol 1999; 6: 33-7.
62. Tepel J, Niehoff P, Bokelmann F et al. Feasibility and early results of interstitial intensity-modulated HDR/PDR brachytherapy (IMBT) with/without complementary external-beam radiotherapy and extended surgery in recurrent pelvic colorectal cancer. Strahlenther Onkol 2005; 181: 696-703.
63. Pachler J, Wille-Jorgensen P. Quality of life after rectal resection for cancer, with or without permanent colostomy. Cochrane Database Syst Rev 2005; CD004323.
64. Shibata D, Guillem JG, Lanouette N et al. Functional and quality-of-life outcomes in patients with rectal cancer after combined modality therapy, intraoperative radiation therapy, and sphincter preservation. Dis Colon Rectum 2000; 43: 752-8.
65. Palmer G, Martling A, Lagergren P, Cedermark B, Holm T. Quality of life after potentially curative treatment for locally advanced rectal cancer. Ann Surg Oncol 2008; 15: 3109-17.
66. Allal AS, Gervaz P, Gertsch P et al. Assessment of quality of life in patients with rectal cancer treated by preoperative radiotherapy: a longitudinal prospective study. Int J Radiat Oncol Biol Phys 2005; 61: 1129-35.
67. Jess P, Iversen LH, Nielsen MB, Hansen F, Laurberg S, Rasmussen PC. Quality of life after cytoreductive surgery plus early intraperitoneal postoperative chemotherapy for pseudomyxoma peritonei: a prospective study. Dis Colon Rectum 2008; 51: 868-74.
68. Turns D. Psychosocial issues: pelvic exenterative surgery. J Surg Oncol 2001; 76: 224-36.
69. Wright FC, Crooks D, Fitch M et al. Qualitative assessment of patient experiences related to extended pelvic resection for rectal cancer. J Surg Oncol 2006; 93: 92-9.
70. Bulow S, Harling H, Iversen LH, Ladelund S; Danish Colorectal Cancer Group. Improved survival after rectal cancer in Denmark. Colorectal Dis 2010; 12(7): e37-42.